Finchley Healthcare Ventures
VC Fund
Finchley Healthcare Ventures is an investment firm invest in venture capital funds specializing in life sciences, leveraging their expertise and network to access a diverse range of investment opportunities.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Finchley Healthcare Ventures invests in
Stages Finchley Healthcare Ventures invests in
Countries Finchley Healthcare Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $67M–$120M
Investment Focus
Industry
- Biotechnology 3 (75%)
- Biopharma 2 (50%)
- Life Science 2 (50%)
- Analytics 1 (25%)
- Health Care 1 (25%)
Stage
- Series B 2 (50%)
- Series A 1 (25%)
Country
- United States 2 (50%)
- Belgium 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Goodman
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Coultreon Biopharma
|
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.Coultreon Biopharma employs extensive experience in disease biology, drug development, and translational science to identify the optimum treatment approach for addressing underlying illness biology withbest-in-class therapeutics. | $125M / Series A / Apr 28, 2026 | |
Triana Biomedicines
|
Triana Biomedicines is building the leading molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high- resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas. | $120M / Series B / Dec 03, 2025 | |
Cartography Biosciences
|
Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets. | $67M / Series B / Oct 02, 2025 | |
Reverb Therapeutics
|
Reverb Therapeutics engages in the development of treatments for cancer and other diseases. | $12M / Seed / Feb 19, 2025 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Finchley Healthcare Ventures invest in?
Finchley Healthcare Ventures invests primarily in Biotechnology, Biopharma and Life Science startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Finchley Healthcare Ventures's check size?
Finchley Healthcare Ventures typically joins rounds of $67M–$120M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Finchley Healthcare Ventures participates in.
How do I contact Finchley Healthcare Ventures?
Public channels for Finchley Healthcare Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Finchley Healthcare Ventures?
The team at Finchley Healthcare Ventures includes David Goodman (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
